Abstract
We have recently developed a risk model specific for patients with lower risk MDS that allows the identification of poor prognosis patients (
Leukemia
. 2008
; 22
:538
-3Disclosures: No relevant conflicts of interest to declare.
Author notes
Corresponding author
2008, The American Society of Hematology
2008
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal